Health Care Select Sector SPDR Fund (XLV) Holdings
XLV holdings summary
as of Oct 23, 2026- Holdings
- 60 positions listed
- Top 10 weight
- 60.8% of net assets
- Effective holdings
- 18 equal-weight equivalent
- Largest holding
- LLY 15.71% Eli Lilly and Company
- Annual turnover
- 3.0% of the portfolio traded
All XLV holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 15.71% | $7.47B | $1.12T | 42.2 |
| 2 | JNJ | Johnson & Johnson | Healthcare | 9.87% | $4.69B | $615.87B | 38.8 |
| 3 | ABBV | AbbVie Inc. | Healthcare | 7.72% | $3.67B | $504.37B | 80.6 |
| 4 | MRK | Merck & Co., Inc. | Healthcare | 5.79% | $2.75B | $360.08B | 115.8 |
| 5 | UNH | UnitedHealth Group Incorporated | Healthcare | 5.69% | $2.70B | $360.32B | 25.8 |
| 6 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 3.81% | $1.81B | $255.13B | 37.1 |
| 7 | AMGN | Amgen Inc. | Healthcare | 3.76% | $1.79B | $233.82B | 26.9 |
| 8 | GILD | Gilead Sciences, Inc. | Healthcare | 3.09% | $1.47B | $193.67B | — |
| 9 | PFE | Pfizer Inc. | Healthcare | 2.75% | $1.31B | $168.60B | 38.9 |
| 10 | ABT | Abbott Laboratories | Healthcare | 2.63% | $1.25B | $181.50B | 33.8 |
| 11 | ISRG | Intuitive Surgical, Inc. | Healthcare | 2.45% | $1.17B | $150.74B | 48.9 |
| 12 | DHR | Danaher Corporation | Healthcare | 2.08% | $990.1M | $161.01B | 40.8 |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.96% | $932.7M | $126.66B | 28.9 |
| 14 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.89% | $900.7M | $122.05B | 13.2 |
| 15 | MDT | Medtronic plc | Healthcare | 1.84% | $877.2M | $121.20B | 23.3 |
| 16 | CVS | CVS Health Corporation | Healthcare | 1.81% | $861.2M | $118.13B | 24.3 |
| 17 | MCK | McKesson Corporation | Healthcare | 1.79% | $851.9M | $117.15B | 26.9 |
| 18 | SYK | Stryker Corporation | Healthcare | 1.64% | $779.3M | $113.02B | 30.5 |
| 19 | MRNA | Moderna, Inc. | Healthcare | 1.42% | $675.9M | $87.04B | — |
| 20 | ELV | Elevance Health Inc. | Healthcare | 1.40% | $663.6M | $92.88B | 19.0 |
| 21 | CI | Cigna Corporation | Healthcare | 1.27% | $605.6M | $79.88B | 12.5 |
| 22 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.21% | $573.6M | $81.41B | 19.6 |
| 23 | COR | Cencora | Healthcare | 1.05% | $498.0M | $65.06B | 25.3 |
| 24 | HCA | HCA Healthcare, Inc. | Healthcare | 1.03% | $488.9M | $99.34B | 15.4 |
| 25 | BSX | Boston Scientific Corporation | Healthcare | 1.01% | $482.4M | $64.33B | 18.0 |
| 26 | CAH | Cardinal Health, Inc. | Healthcare | 0.94% | $446.7M | $58.83B | 35.1 |
| 27 | BDX | Becton, Dickinson and Company | Healthcare | 0.84% | $400.8M | $52.23B | 44.6 |
| 28 | EW | Edwards Lifesciences Corporation | Healthcare | 0.82% | $388.4M | $49.92B | 51.5 |
| 29 | HUM | Humana Inc. | Healthcare | 0.76% | $362.8M | $49.61B | 39.1 |
| 30 | A | Agilent Technologies, Inc. | Healthcare | 0.73% | $349.3M | $48.77B | 34.1 |
| 31 | VEEV | Veeva Systems Inc. | Healthcare | 0.71% | $338.7M | $50.25B | 50.9 |
| 32 | IQV | IQVIA Holdings Inc. | Healthcare | 0.68% | $321.5M | $43.93B | 33.2 |
| 33 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.64% | $305.3M | $44.20B | 39.8 |
| 34 | WAT | Waters Corporation | Healthcare | 0.64% | $303.5M | $42.90B | 110.6 |
| 35 | ILMN | Illumina, Inc. | Healthcare | 0.62% | $295.5M | $39.64B | 49.0 |
| 36 | BIIB | Biogen Inc. | Healthcare | 0.58% | $274.4M | $34.37B | 41.3 |
| 37 | CNC | Centene Corporation | Healthcare | 0.55% | $261.5M | $34.16B | — |
| 38 | RMD | ResMed Inc. | Healthcare | 0.54% | $258.8M | $33.61B | 22.9 |
| 39 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.52% | $245.9M | $32.51B | 36.6 |
| 40 | DXCM | DexCom, Inc. | Healthcare | 0.50% | $239.1M | $32.47B | 34.1 |
| 41 | ZTS | Zoetis Inc. | Healthcare | 0.50% | $237.3M | $32.80B | 13.1 |
| 42 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.47% | $223.2M | $31.42B | 16.0 |
| 43 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.41% | $194.2M | $27.03B | 49.4 |
| 44 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.39% | $186.0M | $25.79B | 26.3 |
| 45 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.39% | $185.7M | $25.94B | 24.6 |
| 46 | VTRS | Viatris Inc. | Healthcare | 0.33% | $158.8M | $21.43B | — |
| 47 | STE | STERIS plc | Healthcare | 0.32% | $153.2M | $21.71B | 27.2 |
| 48 | INCY | Incyte Corporation | Healthcare | 0.29% | $139.2M | $22.92B | 14.4 |
| 49 | RVTY | Revvity, Inc. | Healthcare | 0.28% | $131.5M | $17.03B | 73.0 |
| 50 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.27% | $129.3M | $18.12B | 23.1 |
| 51 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.23% | $110.8M | $14.46B | — |
| 52 | BAX | Baxter International Inc. | Healthcare | 0.20% | $96.2M | $13.07B | — |
| 53 | SOLV | Solventum Corporation | Healthcare | 0.20% | $93.2M | $14.61B | 10.5 |
| 54 | COO | The Cooper Companies, Inc. | Healthcare | 0.18% | $84.7M | $11.02B | 19.9 |
| 55 | TECH | Bio-Techne Corporation | Healthcare | 0.17% | $78.6M | $11.38B | 62.6 |
| 56 | ALGN | Align Technology, Inc. | Healthcare | 0.15% | $72.0M | $10.46B | 25.6 |
| 57 | PODD | Insulet Corporation | Healthcare | 0.15% | $70.9M | $9.79B | 26.4 |
| 58 | UHS | Universal Health Services, Inc. | Healthcare | 0.14% | $68.5M | $10.91B | 7.6 |
| 59 | HSIC | Henry Schein, Inc. | Healthcare | 0.12% | $56.1M | $9.63B | 25.2 |
| 60 | DVA | DaVita Inc. | Healthcare | 0.09% | $44.6M | $11.95B | 15.8 |
Weights as a percentage of net assets. Value held = weight × net assets ($47.55B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
XLV sector breakdown
Sum of the weights of the holdings in each sector.
XLV top industries
XLV overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| TRUH | VanEck Healthcare TruSector ETF | 98.2% | 60 of 60 | — |
| IYH | iShares U.S. Healthcare ETF | 90.6% | 55 of 99 | 0.39% |
| FHLC | Fidelity MSCI Health Care ETF | 86.3% | 60 of 334 | 0.07% |
| VHT | Vanguard Health Care ETF | 85.0% | 60 of 406 | 0.10% |
| IXJ | iShares Global Healthcare ETF | 73.1% | 60 of 106 | 0.42% |
| RXL | ProShares Ultra Health Care | 63.0% | 60 of 61 | 0.93% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the XLV portfolio
Health Care Select Sector SPDR Fund holds 60 positions. The ten largest make up 60.8% of the fund and the top 50 98.4%, so it behaves like a portfolio of about 18 equally weighted stocks. The biggest positions are Eli Lilly and Company (15.71%), Johnson & Johnson (9.87%), AbbVie Inc. (7.72%), Merck & Co., Inc. (5.79%), UnitedHealth Group Incorporated (5.69%).
By sector, Healthcare is 100.1%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 23, 2026; positions change as the fund rebalances.
Related: XLV chart, XLV performance, XLV dividends, XLV valuation, XLV overview.
XLV holdings FAQ
How many holdings does XLV have?
XLV holds 60 positions as of October 23, 2026.
What are the top 10 holdings of XLV?
The ten largest holdings are Eli Lilly and Company (15.71%), Johnson & Johnson (9.87%), AbbVie Inc. (7.72%), Merck & Co., Inc. (5.79%), UnitedHealth Group Incorporated (5.69%), Thermo Fisher Scientific Inc. (3.81%), Amgen Inc. (3.76%), Gilead Sciences, Inc. (3.09%), Pfizer Inc. (2.75%), Abbott Laboratories (2.63%). Together they are 60.8% of the fund.
What percentage of XLV is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 15.71% of net assets, about $7.47B of the fund's $47.55B.
How concentrated is XLV?
The top 10 holdings are 60.8% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) XLV behaves like a portfolio of about 18 equally weighted stocks.